Current modalities of sickle cell disease management

Sickle cell disease (SCD) affects nearly 100,000 people in the United States of America and the sickle gene is present in approximately 8% of black Americans. Among Africans, the prevalence of sickle cell trait (heterozygosity) is as high as 30%. While SCD occurs among varying racial and ethnic grou...

Full description

Saved in:
Bibliographic Details
Published in:Blood science 2020-10, Vol.2 (4), p.109-116
Main Authors: Sanyaolu, Adekunle, Agiri, Ejoke, Bertram, Carl, Brookes, Latasha, Choudhury, Jesy, Datt, Dorina, Ibrahim, Amira, Maciejko, Anna, Mansfield, Anna, Nkrumah, Jasmine, Williams, Martina
Format: Article
Language:English
Subjects:
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sickle cell disease (SCD) affects nearly 100,000 people in the United States of America and the sickle gene is present in approximately 8% of black Americans. Among Africans, the prevalence of sickle cell trait (heterozygosity) is as high as 30%. While SCD occurs among varying racial and ethnic groups, it is more commonly prevalent in individuals of African or African-American descent. This inherited blood disorder causes varying symptoms and complications among affected children and adults and early diagnosis and treatment are essential to help reduce mortality rates. Because there is no cure for SCD, management is vital to survival. Hence, there are different approaches in use to aid those living with SCD; thus, this paper provides insight into the current methods that are implemented in the management and maintenance of this disease.
ISSN:2543-6368
2543-6368
DOI:10.1097/BS9.0000000000000056